The Lancet Psychiatry

Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe

The Lancet Psychiatry Fecha de publicación: 1 de enero de 2022 Autores: Dragana Bugarski-Kirola, MD , Prof Celso Arango, MD, Prof...

Association of school absence and exclusion with recorded neurodevelopmental disorders, mental disorders, or self-harm: a nationwide, retrospective, electronic cohort study...

Lancet Psychiatry Fecha de publicación: 1 de enero de 2022 DOI: https://doi.org/10.1016/S2215-0366(21)00367-9 Autores: Prof Ann John, MD , Yasmin Friedmann, PhD,...

Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study

Lancet Psychiatry Fecha de publicación: 1 de diciembre de 2021 Autores: Hannah J Jones, PhD , Maria Carolina Borges, PhD, Rebecca...

Post-partum psychosis and its association with bipolar disorder in the UK: a case-control study using polygenic risk scores

Lancet Psychiatry Fecha de publicación: Diciembre de 2021 Autores: Arianna Di Florio, MD , Jessica Mei Kay Yang, MRes, Karen Crawford,...

Therapist-supported online remote behavioural intervention for tics in children and adolescents in England (ORBIT): a multicentre, parallel group, single-blind, randomised...

The Lancet Psychiatry Fecha de publicación: 1 de setiembre de 2021 Autores: Prof Chris Hollis, FRCPsych , Charlotte L Hall, PhD,...